A case of lenalidomide-dependent myelodysplastic syndrome

Slides:



Advertisements
Similar presentations
The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients by Sarah Mans, Yara Banz,
Advertisements

Myelodysplastic syndrome. (Bone marrow aspirate, 100 ×
Iron deficiency anemia
Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation by Ming-Tseh Lin, Li-Hui Tseng, Haydar Frangoul,
by Rahul Matnani, and Karthik A. Ganapathi
How I treat LGL leukemia
Flow cytometric immunophenotyping for hematologic neoplasms
by Benjamin J. Frisch, John M. Ashton, Lianping Xing, Michael W
Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury by Shahrouz Ghafoory, Rohan Varshney, Tyler Robison, Karim Kouzbari,
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo by Farideh Miraki-Moud, Essam.
by Udomsak Bunworasate, Hilal Arnouk, Hans Minderman, Kieran L
by Thomas S. Uldrick, and Richard F. Little
Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression by Christian Herens, Frédéric Lambert, Leticia Quintanilla-Martinez,
by Manuel Yepes, Maria Sandkvist, Mike K. K. Wong, Timothy A
Phenotypes of GATA‐1.05/Y germline mutant embryos expressing wild‐type or mutant GATA‐1 transgenes. Phenotypes of GATA‐1.05/Y germline mutant embryos expressing.
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection by Koen Van Besien, Sonali Smith,
Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)
Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid–mediated transactivation is dispensable by Scott C. Kogan, Suk-hyun.
SOX11 holds mantle cell lymphoma’s key to home
by Tara L. Huber, Yi Zhou, Paul E. Mead, and Leonard I. Zon
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals.
Volume 129, Issue 6, Pages (June 2007)
Lymphomas Expressing ALK Fusion Protein(s) Other Than NPM-ALK
Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro by Fei Li, Shijiang Lu, Loyda.
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
ROCK and Rho(ll) in bone marrow
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,
by Jon E. Arnason, Federico Campigotto, Donna Neuberg, and James B
Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS by Ganesan Keerthivasan, Yang Mei,
Erythroid karyorrhexis in myelodysplasia: bone marrow aspirate
Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels by Norio Suzuki, Naruyoshi Suwabe, Osamu.
by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros
by Kelly A. McGowan, Wendy W. Pang, Rashmi Bhardwaj, Marcelina G
Volume 63, Issue 1, Pages (January 2003)
Cytokine Expression Pattern in Bone Marrow Microenvironment after Allogeneic Stem Cell Transplantation in Primary Myelofibrosis  Kais Hussein, Angelika.
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation by Wenbin Xiao, Mariko Yabe, Michael.
Low-dose mifepristone increases uterine natural killer cell cytotoxicity and perforin expression during the receptive phase  Feng Zhou, M.M., Xiu-Ying.
by Alex Aleshin, and Peter L. Greenberg
Hematological phenotypes of hema6 mice.
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis by Tomohiro Umezu, Satoshi Imanishi, Kenko.
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
by Geling Li, Emily Waite, and Julie Wolfson
BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.
MYC DNA is structurally abnormal and MYC protein is overexpressed in MCL cells. MYC DNA is structurally abnormal and MYC protein is overexpressed in MCL.
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency by Pradeep Bangalore-Prakash, Laura.
A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion by Christopher A. Miller, Christopher.
Lineage tracing of murine adult hematopoietic stem cells reveals active contribution to steady-state hematopoiesis by Richard H. Chapple, Yu-Jung Tseng,
ILK knockdown decreases mTOR signaling in PKD kidneys.
Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH by Alexandra Kolenová, Raphaela Schwentner,
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2 by Shadi Khalil, Maja Holy, Stephen Grado, Robert.
A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer tissues. A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer.
SIRT1 is downregulated in human gastric cancer (GC).
Volume 63, Issue 1, Pages (January 2003)
NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy by Guillermo Montalban-Bravo,
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
MtDNA analysis identifies 8 patients with PS in a cohort of DBA patients. mtDNA analysis identifies 8 patients with PS in a cohort of DBA patients. (A)
PD-L1 and tumor-associated macrophages in de novo DLBCL
by Matthew S. Painschab, Kate D
Acute Megakaryocytic Leukemia
Resistance mechanism for ibrutinib in marginal zone lymphoma
Representative staining of bone marrow aspirates collected from a patient at baseline and after 1 cycle of treatment with 45 mg/m2 selinexor + 20 mg dexamethasone,
Hmga2 expression augments BM cells and HSCs with enhancing extramedullary hematopoiesis in JAK2V617F-induced MPN. (A) The total nuclear cell numbers from.
IL-13Rα2 expression is associated to human colon cancer progression and poor survival of patients with colorectal cancer. IL-13Rα2 expression is associated.
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI by Naranie Shanmuganathan, Susan.
Axin induces extensive apoptosis in the lymphocytes of DDTg mice.
A 69-year-old man with small-cell carcinoma from the lung
Axial images from the brain of a 59-year-old woman with mixed features of response, including areas of treatment-related changes and TP. Contrast-enhanced.
Presentation transcript:

A case of lenalidomide-dependent myelodysplastic syndrome by Ira J. Miller, Wei-Tong Hsu, James Weisberger, and Parameswaran Venugopal BloodAdv Volume 1(16):1238-1242 July 11, 2017 © 2017 by The American Society of Hematology

Dysplastic marrow morphology following lenalidomide therapy. Dysplastic marrow morphology following lenalidomide therapy. Representative images of the bone marrow aspirate from September 2013, showing mildly decreased cellularity for age (A; magnification ×60, hematoxylin and eosin stain) with relative erythroid hyperplasia, slightly increased frequency of blasts (B, arrows; magnification ×240, Wright-Giemsa stain), nuclear abnormalities in the erythroid precursors (C, arrows; magnification ×600, Wright-Giemsa stain), and dysplastic small megakaryocytes with binucleation and separated nuclei (D, arrow; magnification ×240, Wright-Giemsa stain). Ira J. Miller et al. Blood Adv 2017;1:1238-1242 © 2017 by The American Society of Hematology

Contemporaneous marrow karyotype showing 1 normal chromosome 7 and 1 probable ring chromosome 7. Contemporaneous marrow karyotype showing 1 normal chromosome 7 and 1 probable ring chromosome 7. The other chromosomes have a normal banding pattern (Giemsa stain, 48-hour culture). Ira J. Miller et al. Blood Adv 2017;1:1238-1242 © 2017 by The American Society of Hematology

Moderate to strong P53 expression in cells of marrow sample with P53 mutation. Moderate to strong P53 expression in cells of marrow sample with P53 mutation. P53 immunostained section of marrow from September 2013 (Leica Bond III automated stainer with manufacturer’s antibody). Magnification ×150; immunostain with diaminobenzidine chromogen and hematoxylin counterstain. Ira J. Miller et al. Blood Adv 2017;1:1238-1242 © 2017 by The American Society of Hematology

Normal appearance of marrow aspirate on follow-up examination 3 years after discontinuation of treatment with lenalidomide (September 2016). Normal appearance of marrow aspirate on follow-up examination 3 years after discontinuation of treatment with lenalidomide (September 2016). Magnification ×310; Wright-Giemsa stain. Ira J. Miller et al. Blood Adv 2017;1:1238-1242 © 2017 by The American Society of Hematology

P53 immunostaining of marrow from September 2016. P53 immunostaining of marrow from September 2016. The extracellular brown pigment is hemosiderin. Rare nuclei showed moderate intensity staining (arrow). Magnification ×140; immunostain with diaminobenzidine chromogen and hematoxylin counterstain. Ira J. Miller et al. Blood Adv 2017;1:1238-1242 © 2017 by The American Society of Hematology